Get high. Become addicted. Commit crimes. Get arrested and be sent to jail. Get released. Repeat. It’s a cycle often destined to persist, in large part because the critical step that is often missing in the process, which is treatment geared toward ensuring that addicts are able to reenter society without the constant threat of imminent relapse.
The Handbook of Evidence-Based Substance Abuse Treatment in Criminal Justice Setting probes the efficacy of corrections-based drug interventions, particularly behavioral treatment. With straightforward interpretation of data that reveals what works, what doesn’t, and what needs further study, this volume navigates readers through the criminal justice system, the history of drug treatment for offenders, and the practical problems of program design and implementation. Probation and parole issues as well as concerns specific to special populations such as women, juvenile offenders, and inmates living with HIV/AIDS are also examined in detail.
The Handbook’s wide-ranging coverage includes:
Biology and genetics of the addicted brain.
Case management for substance-abusing offenders.
Integrated treatment for drug abuse and mental illness.
Evidence-based responses to impaired driving.
Monitoring technology and alternatives to incarceration.
The use of pharmacotherapy in rehabilitation.
This must-have reference work is a comprehensive and timely resource for clinicians, researchers, and graduate students across a variety of disciplines including clinical psychology, criminology and criminal justice, counseling, and educationalpolicy makers.
Author Biography:
Carl Leukefeld is Professor and Chair of the Department of Behavioral Science and founding Director of the Center on Drug and Alcohol Research at the University of Kentucky. He is also the Bell Alcohol and Addictions Endowed Chair. He came to the University of Kentucky in 1990 to establish the Center on Drug and Alcohol Research from the National Institute on Drug Abuse (NIDA) where he filled administrative and research positions. He was also the Chief Health Services Officer of the United States Public Health Service. Dr. Leukefeld has published over 200 articles, chapters, books and monographs. He has taught the undergraduate Alcohol and Problem Drinking Course, the Dependency Behavior graduate course, and the Introduction to Clinical Medicine course for medical students. He currently is a reviewer and consulting editor for five journals, grant reviewer, and has been a member of the NIH Community-Level Health Promotion Study Section and the NIH/NIDA Health Services Initial Review Group. His research interests include treatment interventions, HIV prevention, criminal justice sanctions, and health services. Thomas P. Gullotta is C.E.O. of Child and Family Agency and a member of the psychology and education departments at Eastern Connecticut State University. He is the senior author of the 4th edition of The Adolescent Experience, co-editor of The Encyclopedia of Primary Prevention and Health Promotion, and editor emeritus of the Journal of Primary Prevention. He is the senior book series editor for Issues in Children's and Families' Lives. Tom holds editorial appointments on the Journal of Early Adolescence, The Journal of Adolescent Research and the Journal of Educational and Psychological Consultation. He has published extensively on adolescents and primary prevention. Tom was honored in 1999 by the Society for Community Research and Action, Division 27 of the American Psychological Association with their Distinguished Contributions to Practice in Community Psychology Award. John Gregrich is retired from the Office of National Drug Control Policy (ONDCP) where he served as Chief of the Treatment Branch in the Office of Demand Reduction. From this position he had oversight over, and developed interagency working groups involving, agencies from the Departments of Health and Human Services, Justice, and Education. He annually drafted sections of the National Drug Control Strategy, and developed white papers addressing needle exchange, drug dependent offenders, and drug treatment principles. He developed and oversaw a major Institute of Medicine study of marijuana and a national conference on drug dependent offenders; and served on review panels for, and occasionally contributed to publications of, the National Institute of Justice, the National Institute on Drug Abuse, the Center for Substance Abuse Treatment, and the Institute of Medicine. He achieved parity for drug treatment in federal employee health benefit plans and initiated efforts to establish linkages between primary healthcare providers and drug treatment and prevention programs. John came to ONDCP from the Department of Justice, where he developed, documented, and conducted national demonstrations of the Treatment Alternatives to Street Crime, Drug Abuse Resistance Education, Juror Utilization and Management, and Victim/Witness programs.
